CUFinder

Shengwu Liu

Shengwu Liu

Harvard University

H-index: 19

North America-United States

Contact Shengwu Liu

About Shengwu Liu

Shengwu Liu, With an exceptional h-index of 19 and a recent h-index of 17 (since 2020), a distinguished researcher at Harvard University, specializes in the field of lung cancer, medical oncology, immune therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non–Small Cell Lung Cancer

Acquired Resistance to KRASG12C Inhibition in Cancer

Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non–Small Cell Lung Cancer

Shengwu Liu Information

University

Position

Postdoc Research Fellow at Dana Farber Cancer Institute

Citations(all)

2578

Citations(since 2020)

2201

Cited By

969

hIndex(all)

19

hIndex(since 2020)

17

i10Index(all)

19

i10Index(since 2020)

18

Email

University Profile Page

Google Scholar

Shengwu Liu Skills & Research Interests

lung cancer

medical oncology

immune therapy

Top articles of Shengwu Liu

Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

Cancer Cell

2024/2/20

Eejung Kim
Eejung Kim

H-Index: 10

Hongjun Li
Hongjun Li

H-Index: 17

Shuai Li
Shuai Li

H-Index: 15

Shengwu Liu
Shengwu Liu

H-Index: 12

Suman Mukhopadhyay
Suman Mukhopadhyay

H-Index: 16

Fei Li
Fei Li

H-Index: 3

Fuming Li
Fuming Li

H-Index: 15

Zhaoyuan Fang
Zhaoyuan Fang

H-Index: 4

Juntao Gao
Juntao Gao

H-Index: 5

Yang Chen
Yang Chen

H-Index: 25

Wenjing Yang
Wenjing Yang

H-Index: 7

Itai Yanai
Itai Yanai

H-Index: 30

Liang Hu
Liang Hu

H-Index: 13

Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

Cancer research

2021/10/15

Han Han
Han Han

H-Index: 2

Shuai Li
Shuai Li

H-Index: 15

Ting Chen
Ting Chen

H-Index: 4

Michael Fitzgerald
Michael Fitzgerald

H-Index: 27

Shengwu Liu
Shengwu Liu

H-Index: 12

Jiansheng Wu
Jiansheng Wu

H-Index: 18

Fei Li
Fei Li

H-Index: 3

Hua Zhang
Hua Zhang

H-Index: 22

Hai Hu
Hai Hu

H-Index: 6

Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non–Small Cell Lung Cancer

Cancer discovery

2021/7/1

Shuai Li
Shuai Li

H-Index: 15

Sen Zhang
Sen Zhang

H-Index: 2

Feng Li
Feng Li

H-Index: 5

Biplab Das
Biplab Das

H-Index: 2

Michael Fitzgerald
Michael Fitzgerald

H-Index: 27

Robert J Griffin
Robert J Griffin

H-Index: 29

Shengwu Liu
Shengwu Liu

H-Index: 12

Acquired Resistance to KRASG12C Inhibition in Cancer

New England Journal of Medicine

2021/6/24

Shengwu Liu
Shengwu Liu

H-Index: 12

Jessica Lee
Jessica Lee

H-Index: 0

Kavita Garg
Kavita Garg

H-Index: 7

Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non–Small Cell Lung Cancer

Clinical Cancer Research

2020/5/15

Man Xu
Man Xu

H-Index: 0

Shuai Li
Shuai Li

H-Index: 15

Shengwu Liu
Shengwu Liu

H-Index: 12

Ting Chen
Ting Chen

H-Index: 4

See List of Professors in Shengwu Liu University(Harvard University)